uric acid has been researched along with Coronary Restenosis in 3 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperuricemia is not associated with poor clinical outcomes after repeat PCI for ISR lesions." | 1.48 | Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis. ( Hong, SJ; Jeong, HS; Joo, HJ; Kook, H; Lee, SH; Lim, DS; Park, JH; Yu, CW, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, W | 1 |
| Ding, K | 1 |
| Bao, J | 1 |
| Hu, Y | 1 |
| Gui, Y | 1 |
| Ye, L | 1 |
| Wang, L | 1 |
| Joo, HJ | 1 |
| Jeong, HS | 1 |
| Kook, H | 1 |
| Lee, SH | 1 |
| Park, JH | 1 |
| Hong, SJ | 1 |
| Yu, CW | 1 |
| Lim, DS | 1 |
| Turak, O | 1 |
| Canpolat, U | 1 |
| Özcan, F | 1 |
| Mendi, MA | 1 |
| Oksüz, F | 1 |
| Işleyen, A | 1 |
| Gürel, OM | 1 |
| Çay, S | 1 |
| Aras, D | 1 |
| Aydoğdu, S | 1 |
3 other studies available for uric acid and Coronary Restenosis
| Article | Year |
|---|---|
Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Per | 2023 |
Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.
Topics: Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Humans | 2018 |
Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
Topics: Angina, Unstable; Coronary Angiography; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male | 2014 |